Form D · Private Equity Fund

Sands Capital Life Sciences Pulse Fund C-1-GP, L.P.

Arlington, VA · CIK 0001781278

Offering snapshot reported Jun 8, 2020 · SEC filing

Reported sold
$470K
Offering amount: $470K
Investors reported
12
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 25, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$235K$470KJul 3, 2019: $170,000.00Jul 3, 2019Jun 8, 2020: $470,000.00Jun 8, 2020

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$170,000 → $470,000
  • Reported investors6 → 12

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 8, 2020Amendment$470,000$300,000vs Jul 3, 201912SEC filing
Jul 3, 2019Initial$170,000No comparison6SEC filing

Offering details

Securities
Pooled investment fund
Exemptions
06b, 3C, 3C.1
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-343522

Source: Form D, filed Jun 8, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jonathan Goodman Executive
Erin Soule Executive
Job Taylor Executive
Stephen Zachary Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
C/O Sands Capital Ventures, Llc 1000 Wilson Boulevard, Suite 3000
Arlington, VA, 22209